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Abstract
Background: Nasal polyposis is the benign protrusion of 
soft tissue into the nasal cavity, with multifactorial origin. 
This study is designed to examine the suggested role of 
IgE and CD  and CD  lymphocytes in the pathogenesis of 4 8
nasal polyposis.
Method: Blood samples were taken from 32 patients with 
chronic polypoid sinusitis and 32 controls. CD  and CD  4 8
total lymphocyte count were determined by flow cytometry 
and the level of serum IgE was measured by ELISA. Nasal 
discharge samples were also collected for determining 
IgE level in both patients and controls during surgery.
Results: In 68.8% of patients a history of allergy was 
present. The level of nasal discharge IgE was significantly 
higher (p<0.001) in patients compared to controls, but the 
difference between serum IgE levels was not significant 
(p> 0.05). CD  concentration and blood lymphocytes were 8
significantly higher (p<0.001) in the patients group, while 
CD  concentration was significantly lower (p<0.001) in 4
them. Finally, CD /CD  ratio was significantly lower 4 8
(p<0.001) in the patients group.
Conclusion: This study suggests that a change in the 
amount of CD  and CD  lymphocytes and an increased 4 8
level of local IgE contribute to nasal polyposis, but the 
results should be confirmed in more extensive studies 
including cytokine analyses. Such increasing insights in 
the pathophysiology of nasal polyposis open perspectives 
for new pharmacological treatment options, with 
immunologic factors as potential targets. 
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Introduction 
The history of nasal polyps dates back to over three 
thousand years ago in India, where a type of curette was 
1
described for eradicating nasal polyps.  Nasal polyps are 
seen in patients of all ages. They are present in 
approximately 2% of the general population. There is at 
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1least a 2:1 male to female predominance.  The 
frequency of nasal polyps increases with age, reaching 
a peak in individuals 50 years and older. Nasal 
polyposis is not a disease, but a physical finding with a 
2number of causes and associated conditions.  Most 
commonly, 25%-30% of patients have asthma, while 
approximately 12% have aspirin intolerance. Nasal 
polyps are also seen in 0.1% of children and 20% of 
patients with cystic fibrosis. They are seen in 50% of 
patients with eosinophilic vasculitis of Churg Strauss 
syndrome. They are also seen in disorders of ciliary 
motility like Kartagener's syndrome, as well as other 
genetic syndromes such as Young's syndrome, which is 
a bronchopulmonary disease accompanied by 
3azoospermia.
Proposed mechanisms implicated in the development 
of nasal polyps include: allergy, infection, autonomic 
imbalance, mucopolysaccharide abnormalities, 
enzyme abnormalities, drug sensitivity and mechanical 
1
obstructions.  
Nasal polyps consist of respiratory epithelium covering 
a very edematous stroma infiltrated by a large number 
of inflammatory cells with eosinophils being the 
1
predominant group.  Bilateral nasal polyposis is 
associated with concentrations of IgE in nasal polyp 
tissue. Infiltrated mast cells demonstrate ultra structural 
signs of degranulation, associate with continuous 
release of histamine, which is found in higher 
2concentrations in polyp fluid.
The presence of controversies in previous studies that 
evaluated the lymphocyte subpopulations and their 
production of cytokines and IgE in serum and nasal 
secretion in order to elucidate the role of immunologic 
factors in the process of nasal polyps as well as 
difference in their results lead us to do further 
5-10investigations.  So in this sequel, this study is 
designed to examine the suggested role of IgE, and CD  4
and CD  lymphocytes in the pathogenesis of nasal 8
polyposis.
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Patients and Methods
Seventeen men and 15 women, ranging in age from 20 to 
71 years (mean, 46.6 years), who had chronic 
rhinosinusitis with diffuse nasal polyps and underwent 
endoscopic sinus surgery, were included in this study. All 
of the patients gave written informed consent and the 
study was approved by the Institutional Review Board 
and ethics committee of Ahwaz Jondishapour University 
of Medical Sciences. The demographic data of the study 
and control groups have been given in the Table I. The 
Peripheral blood samples were taken from 32 patients for 
whom the diagnosis of chronic polypoid sinusitis was 
established, and 32 control patients who were candidates 
for septoplasty who had a negative history of allergy and 
sinusitis. The samples were sent to laboratory for 
lymphocyte count and determination of amounts of CD  4
and CD  lymphocytes by flow cytometry (Becton 8
Dickinson Co., USA), and serum IgE by ELISA. Nasal 
discharge samples were also collected for determining 
local IgE level in both patients and controls during 
surgery.
Monoclonal antibodies used in flow cytometry analysis 
included fluorescein isothiocynate (FITC) and 
phycoerythrin (PE) -conjugated against CD  and CD  4 8
markers (Dako Co., Danmark). All samples were washed 
in sodium perborate (PBS) after staining procedures, 
followed by exposure to a lysing reagent again. FITC and 
PE-conjugated mouse IgG1 were incubated with cells 
obtained from Patients in parallel to negative controls. 
Prepared immunostaining cell suspensions were 
submitted to flow cytometry analysis. IgE levels were 
measured in serum and nasal discharge samples using a 
kit prepared from PAD TANELAM Company of Iran, and 
were recorded based on international units per milliliter 
(IU/ml). 
Statistical analysis: The data obtained were analyzed 
statistically using the t-test. P-values less than 0.05 were 
considered as significant. 
Results
IgE level of nasal discharge was significantly higher 
(p<0.001) in patients compared to the control group; it 
was 84.6 IU/ml in the patients group 20.9 IU/ml in the 
control group. Also the difference in serum IgE was not 
significant (p>0.05) with a values of 130.5 IU/ml in 
Patients and 127.6 IU/ml in controls (Table II). In 68.8% 
of patients a history of allergy was present. CD8 
concentration (46.8% in patients vs 28.3% in controls) 
and percentage of peripheral blood lymphocytes (17.7% 
 
in Patients and 31.6% in controls) were significantly 
different (p<0.001 for both comparisons) between the 
two groups (Table II). Ironically, CD4 concentration was 
significantly lower (p<0.001) in patients (Table II). 
Finally, CD4/CD8 ratio was significantly lower (p<0.001) 
in the patients (Table II). 
Table I: Demographic and immunological features of 
patients and control groups 
Table II: difference in variables between patients 
and control groups
Discussion
Although the etiology of nasal polyposis is still not 
revealed, insights in the pathogenesis have largely 
11
expanded over the last years.  There are two models 
suggested for the development of nasal polyposis: one 
states that this condition is caused by the up-regulation 
of cytokines leading to increased eosinophil 
degranulation; the other mechanism suggests that 
injury to the airway epithelial cells induced by an 
allergen, viruses or trauma leads to defective 
transmembrane regulators, which in turns alters sodium 
chloride flux in the epithelial cell and finally directs to 
3edema. 
A consistent feature in nasal polyposis is a prominent 
infiltration of inflammatory cells, and it has been 
proposed that alteration of immune regulation could be 
implicated as a contributing factor. The eosinophil 
leukocyte is the dominant cell in polyps; consequently, 
allergy has been considered as an important etiology for 
4nasal polyps. 
The prevalence of allergy in patients with nasal polyps 
varies from 10% to 54%. There is a coincidence of 
asthma and nasal polyps but the association between 
polyposis and atopic conditions is not clear. It has been 
newly suggested that Staphylococcus Aureus may 
have a role in formation of nasal polyps. This pathogen 
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Variables Patients (n = 32) Control (n = 32) P-Value 
Median age (year) 53 46 0.341 
Gender (Male: Female) 15:17 13: 19 1.0 
Elevated serum IgE (frequency) 22 (68.75%) 3(9.37%) 0.001 
Blood eosinophilia 27 (84.37%) 2(6.25%) 0.001 






Patients group (n = 32) 
(Mean ÿ± SD)  
 
Control group (n = 32) 




IgE level of nasal discharge 
(IU/ml) 
 
84.69 ÿ± 6.94  
 




Serum IgE (IU/ml) 
 
130.55 ÿ± 9.87  
 





CD8 concentration (%) 
 
46.88 ÿ± 3.71  
 





Percentage of peripheral blood lymphocytes  
(%) 
 
17.72 ÿ± 1.35  
 





CD4 concentration (%) 
 
 
38.25 ÿ± 3.01  
 







0.8409 ÿ± 0.14  
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is found in the nasal samples obtained from these 
patients, although the significance is unclear. The bacteria 
may secrete exotoxins that act as superantigens and are a 
possible trigger for local IgE production in nasal 
11-13polyposis.
It should be emphasized that the presence of eosinophils 
in the polyps does not depend on the presence of allergy 
or IgE-mediated hypersensitivity disorders, but is related 
to up-regulation of appropriate cytokines and growth 
factors such as interleukin-1â, tumor necrosis factor, 
14
macrophage colony stimulating factor.  All these 
cytokines have direct or indirect effects on the 
transmigration of eosinophils from the microvasculature 
into the lamina propria of nasal polyps. In one study, 
Benrstein et al. showed that two subpopulations of 
lymphocytes, CD  and CD , have significant roles in 4 8
production of these cytokines. Their findings imply that 
there are significant differences between the percentage 
of lymphocytes producing these cytokines in nasal polyps 
and peripheral blood. Lymphocytes infiltrated in nasal 
polyps may derive from a source other than peripheral 
2, 15blood.  They may be derived from both the local mucosal 
immune system as well as from random migration of 
15, 16
peripheral blood lymphocytes.
Ihan and Suskovic evaluated CD  and CD  cells isolated 4 8
from nasal tissue in allergic and nonallergic polypoid 
patients, and found a significant increased expression of 
intercellular adhesion molecule-1 (ICAM-1) molecules on 
CD  cells in nonallergic compared to allergic patients. This 8
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finding may reflect the difference in cytotoxic immune 
16
response between allergic and nonallergic patients,  
although it is inconsistent with the result of a study by 
Hel, in which the expression percentage of CD ,CD  3+ 4+
cells appeared to be significantly higher than that of 
13,17CD ,CD  cells.3+ 8+
A survey conducted by Muluk implies on the role of T-
helper lymphocytes in the pathophysiology of chronic 
sinusitis, and CD  T-helper cells in particular are 4+
thought to be predominant at the initiation and regulation 
14, 18of inflammation.
Our study shows that a change in the amount of CD  and 4
CD  lymphocytes and an increase in the level of local IgE 8
to be important, which suggests that local allergy may 
play a key role in sinonasal polyposis; however, the 
results should be confirmed in more extensive studies 
which recruit cytokine analysis. Increasing insights in 
the pathophysiology of nasal polyps let us gain open 
perspectives for new pharmacological options with CD  4
and CD  lymphocytes and local IgE secretion as 8
potential targets for treatment. We hope that it would 
enable us to obtain a deeper insight into the local 
immune events and further to clarify the etiology and 
pathogenesis of nasal polyps and their relation to 
allergy.
Acknowledgements
The authors would like to thank Farzan Institute for 
Research and Technology for technical assistance.
References
1. Raymond G, Salvin L. Nasal polyp and sinusitis. Middleton JR, 
Reed CE, Elliot EF, et al, eds. Allergy principles and practice. 5th 
ed. St Louis: Mosby Year Book Inc; 1998.pp. 393-403
2. Bachert C, Gevaert P, Holtappels G, Van Cauwenberge P. Total 
and specific IgE in nasal polyps is related to local eosinophilic 
inflammation. J Allergy Clin Immunol 2001; 107: 607-14.
3. Bernstin JM. Nasal Polyp Diseases of the sinuses, Diagnosis 
and management. Kennedy, Bolger, Zinreich. London: BC 
Decker; 2001
4. Setsuko M, Nakamura H. Inflammatory cells in nasal mucosa 
and nasal polyps. Auris Nasus Larynx 2000; 27: 59-64.
5. Liu CM, Shun CT, Hsu MM. Lymphocyte subsets and antigen-
specific IgE antibody in nasal polyps. Ann Allergy. 1994; 
72(1):19-24.
6. Fokkens WJ, Holm AF, Rijntjes E, Mulder PG, Vroom TM. 
Characterization and quantification of cellular infiltrates in nasal 
mucosa of patients with grass pollen allergy, non-allergic 
patients with nasal polyps and controls. Int Arch Allergy Appl 
Immunol. 1990; 93(1):66-72
7. Bellioni P, Ruscito P, Bevilacqua P, Maurizi M, Larocca LM, 
Maggiano N, Capelli A. Recent advances concerning 
etiopathogenesis of nasal polyposis. Acta Otorhinolaryngol Ital. 
1989; 9(1):3-13
8. Conley DB, Tripathi A, Seiberling KA, Schleimer RP, Suh LA, 
Harris K,Paniagua MC, Grammer LC, Kern RC. 
Superantigens and chronic rhinosinusitis: skewing of T-cell 
receptor V beta-distributions in polyp-derived CD4+ and 
CD8+ T cells. Am J Rhinol. 2006; 20(5):534-9.
9. Hao J, Pang YT, Wang DY. Diffuse mucosal inflammation in 
nasal polyps and adjacent middle turbinate. Otolaryngol Head 
Neck Surg. 2006; 134(2):267-75.
10. Verbruggen K, Van Cauwenberge P, Bachert C. Anti-IgE for 
the treatment of allergic rhinitis--and eventually nasal polyps? 
Int Arch Allergy Immunol. 2009; 148(2):87-98.  
11. Gevaert P, Holtappels G, Johansson SG. Organization of 
secondary lymphoid tissue and local IgE formation to 
staphylococcus aureus entrotoxins in nasal polyp tissue. 
Allergy 2005; 60: 71-9.
12. 12.Conley DB, Tripathi A, Ditto AM. Chronic sinusitis with nasal 
polyps: Staphylococcal exotoxin immunoglobulin E and 
cellular inflammation. Am J Rhinol 2004 ;18: 273-8.        
13. Suh YJ, Yoon SH, Sampson AP, Kim HJ. Specific 
immunoglobulin E for staphylococcus entrotoxins in nasal 
polyps from patients with aspirin- intolerant asthma. Clin Exp 
Allergy 2004; 34: 1270-5.
Nigerian Journal of Medicine, Vol.18, No.4 October- December 2009, ISSN 1115 2613
383
14. Pastorello EA, Incorvaia C, Riario-Sforza GG. Importance of 
allergic etiology in nasal polyposis. Allergy1994;15: 151-5.
15. Bernstein JM, Ballow M, Rich G. Lymphocyte subpopulations 
and cytokines in nasal polyps: is there a local immune system in 
the nasal polyp? Otolaryngol Head and neck Surg 2004; 130: 
526-35.
16. Ihan A, Suskovic S. Flow cytometric analysis of lymphocytes 
isolated from nasal polyps. Folia Biol 1997;43: 15-8.                                         
17. He L, Shi J, Xu G. The T-lymphocytes subsets expression in 
the human recurrent nasal polyps. Lin Chuang Er Bi Yan Hou 
Ke Za Zhi 2004;18: 97-9.
18. Muluk NB, Atasoy P. Localization of T cells and subtypes in the 
paranasal sinus and turbinate mucosa in patients with chronic 
sinusitis. J Otolarryngol 2004;33:235-42
# # ¥Immunologic Factors in Patients:  * Nikakhlagh S * Ghafourian-Boroujerdnia M, Saki N Soltan-Moradi M R; Rahim F, 
Nigerian Journal of Medicine, Vol.18, No.4 October- December 2009, ISSN 1115 2613
